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A Game Changer for Congenital Cardiology*Michael J. Landzberg, MD“I was so much older then,
I’m younger than that now”
—Bob Dylan (1)A cross the years, standardization of care forchildren and adults with congenital heartdisease has paled in comparison with that
witnessed for acquired heart disease. Congenital
cardiology’s experience with multicenter outcomes
trials, national registries, development and assess-
ment of provider-centered and patient-centered
quality indicators, care guidelines, and certiﬁcation
of specialty training have either been limited in scope
or in foundation data, are newly developing, or have
yet to be embarked upon. For multiple reasons,
including the perception of an imperative to act and
intervene in the face of impending poor outcomes at
young ages, early decades of growth and development
of the congenital cardiology ﬁeld appeared to perpet-
uate amindset of “invention turned into intervention”
across the lifelong spectrum of pathology. This culture
allowed novel technological advances and both paral-
leled and likely contributed to documented improve-
ments in both acute and longer term survival for
some of medicine’s most at-risk populations.
“For the times they are a-changin’”
—Bob Dylan (2)
The difference between “invention” and “innova-
tion” can be blurred in the process of discovery, as the
demonstration of value and worth attendant with*Editorials published in the Journal of the American College of Cardiology
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of JACC or the American College of Cardiology.
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longitudinal assessment and analysis. As con-
genital cardiologists felt increasingly established (and
empowered to self-reﬂect) and as stark risks of mor-
tality shifted away from early and later pediatric
years through a more chronic phase in young and
older adulthood, the need to assess and analyze the
lifelong implications (via structure and rigor in acute
and longitudinal outcomes assessment over the age
spectrum) of congenital interventions was increas-
ingly recognized and accepted. Now, through the
vision of National Cardiovascular Data Registry’s
(NCDR’s) IMPACT (Improving Pediatric and Congen-
ital Treatment) Registry, this awareness is placed into
widespread application.
“I came in from the wilderness,
a creature void of form”
—Bob Dylan (3)
Numerous efforts to catalogue and register
congenital interventions preceded IMPACT. The Val-
vuloplasty and Angioplasty of Congenital Anomalies
(VACA) Registry, an unfunded collection of data from
27 congenital catheterization centers, began in 1982
and called for voluntary reporting of limited and basic
data elements (4). VACA investigators’ demonstration
of factors associated with increased procedural risks
for most common congenital interventions promul-
gated a sense of collaborative purpose that continued
through the mid-1990s. In the mid-2000s, small
groups of partnering practices and institutions
(MAGIC [Mid-Atlantic Group of Interventional Cardi-
ology] and the CCISC [Congenital Cardiovascular
Interventional Study Consortium]), trialed limited
structured systems for capturing speciﬁc proce-
dural and outcomes data elements. The ongoing
multicenter collaborative Congenital Cardiac Cathe-
terization Project on Outcomes (C3PO), funded by
participating institutions, created a data collection
model of sufﬁcient scope to allow development of risk
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2453adjustment scales and more rigorous description and
assessment of procedural technique and adversity
across the patient age spectrum seen in pediatric
cardiology practices (5). C3PO increased recognition
of the need for deﬁnition of procedural goals, tech-
nique success and adversity; standardization of indi-
cation, procedure follow, and assessment; and data
capture, core review, attribution, and systematic
analysis. Combined, these registries demonstrated
areas of glitch, as well as the need for future feedback
systems that would allow development of improved
and meaningful risk stratiﬁcation schema, assessment
of attribution and outcomes (on the basis of currently
accepted indications and procedure), and determina-
tion of value and worth. With such accomplishment,
indication and procedural technique reﬁnements
could occur, with subsequent improvement in care for
persons affected by congenital heart disease.SEE PAGE 2439“Let us not talk falsely now,
the hour is getting late”
— Bob Dylan (6)
In this issue of the Journal, Moore et al. (7), who
comprise members of the steering committee of
IMPACT, report on ﬁndings from the initial efforts of
this registry. The ﬁnding may underwhelm the casual
reader, but on further reﬂection, the serious reader
will be impressed by the humility demonstrated in
the pursuit of accuracy. Beginnings of procedural
deﬁnitions emerged, and patient and procedural
characteristics are catalogued; signiﬁcant limitations
in these are recognized, allowing the registry the
ability to learn, reﬂect, and reﬁne. The authors avoid
terms such as success related to procedure or out-
comes, recognizing that the true 2-fold triumph of
these initial efforts: bringing together a congenital
community that overwhelmingly endorsed partici-
pation in this registry and avoiding overstatement or
overinterpretation of results. In so doing, Moore et
al., representing IMPACT Registry participants,
conﬁrm that the congenital cardiology ﬁeld has
matured and come of age and can now can tackle
some of its most difﬁcult questions relating to out-
comes, quality, and worth.
“How many deaths will it take till [we know]
that too many people have died?”
—Bob Dylan (8)
The NCDR has long demonstrated that with regis-
tries comes standard and improved abilities to assess
outcomes meaningful to patient care practice, sci-
ence, and health care resource allocation. Much creditis due to the American College of Cardiology and
its Adult Congenital/Pediatric Cardiology Council, as
well as to the overarching NCDR and IMPACT Registry
leadership for their creation and rapid-phase begin-
ning via collection of important procedural data from
congenital cardiology centers. The efforts of Moore
et al. (7) in this issue of the Journal, representing the
steering committee and the many IMPACT partici-
pants, deserve praise. However, from these humble
beginnings, great expectations remain. The stage has
been clearly set for the future of congenital cardiol-
ogy. Where must IMPACT and congenital cardiology
go from here?
 The IMPACT Registry has the potential to drive
practice toward the mean of measured perfor-
mance. Until outcomes, worth, and value are
determined for particular aspects of interventions,
care must be taken to set the highest expectations
for procedural accomplishment, as well as for both
completeness and accuracy of documentation.
 Structure and rigor must be sustained at all levels
of review, analysis, and reﬂection. The current
effort by Moore et al. (7) must lead to far more
sophisticated and aggressively critical analyses of
speciﬁc aspects of speciﬁc interventions. The ﬁeld
must call itself to task as limitations and biases
must be recognized and reﬂected on and steps
taken to improve deﬁnition, data collection, and
performance. Analysis must lead to change in care
recommendation and, ultimately, in practice.
 IMPACT collects data largely from pediatric
congenital heart disease centers. It has long been
recognized that a large (if not major) percent of sur-
gical and catheter-based interventions in adults
with congenital heart disease (and general medical
care for such adults), who now comprise more than
one-half of the congenital heart disease population,
are performed by physicians not identiﬁed as
congenital heart disease specialists and not neces-
sarily in conjunction with congenital heart disease
specialty care teams (9). The morbid and mortal
consequences of such practices were questioned,
placing global cooperation of the pediatric, internal
medicine, and congenital cardiology communities
into tension (10). Only with incorporation of all in-
ternal medicine cardiology practices (such as those
already in other adult NCDRs) into IMPACT will the
totality of real-world practice of interventions
for young and older adults with congenital heart
disease be recognized. When this occurs, the
performance, outcomes, quality, and worth of
concentrating care within a subspecialty can be
appropriately examined, and our larger
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most appropriately together toward common goals.
 Structural intervention is a small part of the whole
of “innovation” and improved outcomes. Congen-
ital cardiology has seen a shift in mortality, for
some from neonatal to so-called interstage periods
(the years or decades between interventions) and
for most others, pushed into premature adulthood.
The modern natural history of congenital heart
disease in its variety, as well as the longer
term physiological consequences of medical in-
terventions and aging, remains largely unknown or
uncertain. An organized national longitudinal reg-
istry of medical (in addition to structural inter-
vention) outcomes for all aged persons withcongenital heart disease is deplorably lacking and
immediately required. The task appears enormous
for the >2 million affected patients with congenital
heart disease in the United States, but leaving it
undone would create even more enormous gaps in
knowledge, science, and care. The call to action is
here and now; IMPACT has begun the task. Failure
to complete it is unacceptable.
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